New-Zealand company MARS Bioimaging Ltd has used technology developed at CERN to perform the first colour 3D X-ray of a human body, offering more accurate medical diagnoses.
The high-luminosity LHC promises a quantifiable return to society in terms of scientific, economic and cultural value.
The Big Science Business Forum (BSBF), held in Copenhagen, Denmark, saw delegates discuss opportunities in the current big-science landscape
The first annual knowledge-transfer thematic forum on medical applications takes place at CERN
Knowledge transfer has become an established part of CERN’s programme, says Frédérick Bordry.
Global healthcare company Novartis has announced plans to acquire Advanced Accelerator Applications (AAA), a spin-off radiopharmaceutical firm established by former CERN physicist Stefano Buono in 200...
The accelerator technology underpinning Europe’s first particle-therapy facilities was driven by the TERA Foundation during the past 25 years.
CERN’s MEDICIS facility is producing novel radioisotopes for medical research.
Proton and ion therapy set to transform global cancer treatment
Working towards medical linacs for challenging environments